Form 4 holding
Chief Acctg Officer, Int. CFO
Calidi Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 278,790
- Estimated value
- $501,822
- Report date
- 12 Sep 2023
- Price
- $1.80
- Ownership
- Direct
Tony T. Kalajian - Chief Acctg Officer, Int. CFO at Calidi Biotherapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Chief Acctg Officer, Int. CFO
- Issuer Symbol
- CLDI on NYSE, CLDWW on OTC
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Tony T. Kalajian since 20 May 2025
Holdings reported by Tony T. Kalajian for Calidi Biotherapeutics, Inc.
Transactions reported by Tony T. Kalajian for Calidi Biotherapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.